title: Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
abstract: Varicella-zoster virus (VZV) causes varicella, establishes latency in sensory ganglia, and reactivates as herpes zoster. Human dorsal root ganglia (DRGs) xenografts in immunodeficient mice provide a model for evaluating VZV neuropathogenesis. Our investigation of the role of glycoprotein I (gI), which is dispensable in vitro, examines the functions of a VZV gene product during infection of human neural cells in vivo. Whereas intact recombinant Oka (rOka) initiated a short replicative phase followed by persistence in DRGs, the gI deletion mutant, rOkaDeltagI, showed prolonged replication with no transition to persistence up to 70 days after infection. Only a few varicella-zoster nucleocapsids and cytoplasmic virions were observed in neurons, and the major VZV glycoprotein, gE, was retained in the rough endoplasmic reticulum in the absence of gI. VZV neurotropism was not disrupted when DRG xenografts were infected with rOka mutants lacking gI promoter elements that bind cellular transactivators, specificity factor 1 (Sp1) and upstream stimulatory factor (USF). Because gI is essential and Sp1 and USF contribute to VZV pathogenesis in skin and T cells in vivo, these DRG experiments indicate that the genetic requirements for VZV infection are less stringent in neural cells in vivo. The observations demonstrate that gI is important for VZV neurotropism and suggest that a strategy to reduce neurovirulence by deleting gI could prolong active infection in human DRGs.
authors: Departments of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA. zerboni@stanford.edu
authors: Leigh
authors: L
authors: Zerboni
authors: Mike
authors: M
authors: Reichelt
authors: Carol D
authors: CD
authors: Jones
authors: James L
authors: JL
authors: Zehnder
authors: Hideki
authors: H
authors: Ito
authors: Ann M
authors: AM
authors: Arvin
mesh_terms: D000818:Animals; D002644:Chickenpox / Q000276:immunology* / Q000473:pathology; D004279:DNA, Viral / Q000235:genetics; D005727:Ganglia, Spinal / Q000473:pathology / Q000637:transplantation / Q000821:virology*; D017353:Gene Deletion; D016679:Genome, Viral; D014645:Herpesvirus 3, Human / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D006801:Humans; D051379:Mice; D016366:Open Reading Frames; D011401:Promoter Regions, Genetic; D011995:Recombination, Genetic; D014158:Transcription, Genetic; D014183:Transplantation, Heterologous; D014759:Viral Envelope Proteins / Q000235:genetics*; D014764:Viral Proteins / Q000235:genetics
chemical_list: D004279:DNA, Viral; D014759:Viral Envelope Proteins; D014764:Viral Proteins; C056913:glycoprotein E, varicella-zoster virus
references: J Virol. 1999 Dec;73(12):10514-8
references: 10559370
references: J Virol. 2000 Jul;74(14):6600-13
references: 10864674
references: J Virol. 2000 Dec;74(23):10975-83
references: 11069992
references: J Virol. 2000 Dec;74(23):11377-87
references: 11070038
references: J Virol. 2001 Jan;75(1):323-40
references: 11119602
references: Arch Virol Suppl. 2001;(17):57-70
references: 11339551
references: J Virol. 2001 Oct;75(19):9483-92
references: 11533210
references: J Virol. 2002 Aug;76(16):8468-71
references: 12134050
references: J Virol. 2003 Jan;77(1):489-98
references: 12477854
references: Virology. 2002 Dec 20;304(2):176-86
references: 12504560
references: Virology. 2004 May 20;323(1):85-90
references: 15165821
references: J Exp Med. 2004 Oct 4;200(7):917-25
references: 15452178
references: J Cell Biol. 1973 May;57(2):551-65
references: 4121290
references: J Cell Biol. 1981 Jun;89(3):653-65
references: 6166621
references: Nature. 1983 Dec 1-7;306(5942):478-80
references: 6316159
references: JAMA. 1984 Jul 20;252(3):355-62
references: 6330386
references: N Engl J Med. 1988 Mar 3;318(9):543-8
references: 2828948
references: Proc Natl Acad Sci U S A. 1988 Apr;85(7):2362-6
references: 2832852
references: J Virol. 1996 May;70(5):2789-96
references: 8627753
references: J Virol. 1997 Jan;71(1):110-9
references: 8985329
references: J Virol. 1997 Sep;71(9):6455-64
references: 9261363
references: J Virol. 1992 May;66(5):3032-41
references: 1313916
references: J Virol. 1993 Jan;67(1):305-14
references: 8380078
references: J Virol. 1994 Feb;68(2):834-45
references: 8289387
references: J Virol. 1994 Aug;68(8):5275-9
references: 8035525
references: J Virol. 1995 Sep;69(9):5236-42
references: 7636965
references: J Virol. 1997 Sep;71(9):6913-20
references: 9261418
references: J Virol. 1997 Nov;71(11):8279-88
references: 9343180
references: J Virol. 1998 Feb;72(2):1542-51
references: 9445058
references: Proc Natl Acad Sci U S A. 2005 May 3;102(18):6490-5
references: 15851670
references: N Engl J Med. 2005 Jun 2;352(22):2271-84
references: 15930418
references: J Virol. 2005 Sep;79(17):10875-89
references: 16103140
references: J Virol. 2005 Sep;79(18):11990-2001
references: 16140775
references: J Virol. 2005 Nov;79(22):14079-87
references: 16254342
references: J Virol. 2006 Apr;80(7):3167-79
references: 16537585
references: J Virol. 2006 Oct;80(19):9481-96
references: 16973553
references: Cell. 2006 Oct 20;127(2):305-16
references: 17055432
references: J Virol. 2007 Apr;81(7):3229-39
references: 17251302